Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05558436

Comparison of Diagnostic Sensitivity Between ctDNA Methylation and CEA in Colorectal Cancer

Sponsor: Nanfang Hospital, Southern Medical University

View on ClinicalTrials.gov

Summary

This is a prospective diagnostic study. This study is to compare the performance between circulating tumor DNA (ctDNA) methylation and carcinoembryonic antigen (CEA) in detecting colorectal tumor. Firstly, based on the identification of differential ctDNA methylation biomarkers, the diagnostic model is established and the diagnostic performance was compared with that of CEA. Secondly, the stage stratification model was established preliminarily based on differential ctDNA methylation biomarkers and the performance was also compared with that of CEA.

Official title: Comparison of Diagnostic Sensitivity Between Circulating Tumor DNA Methylation and Carcinoembryonic Antigen in Colorectal Cancer

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

OBSERVATIONAL

Enrollment

662

Start Date

2022-06-01

Completion Date

2024-12-31

Last Updated

2024-05-10

Healthy Volunteers

No

Interventions

DIAGNOSTIC_TEST

Genome-wide methylation profiling

Detection for colorectal tumor-specific ctDNA methylation biomarkers

Locations (1)

Nanfang Hospital, Southern Medical University

Guangzhou, Guangdong, China